Spectrum, Allos Stretch Tender Offer After FTC Info Request
Spectrum Pharmaceuticals Inc. has extended its $206 million tender offer for Allos Therapeutics Inc. after federal antitrust regulators asked the drug companies to turn over more information on the planned deal,...To view the full article, register now.
Already a subscriber? Click here to view full article